AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo. The FDA approved Emblaveo, a combination of aztreonam and avibactam, for use in combination with ...

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Optimally, one would use cefixime or ceftriaxone in those ... sulfamethoxazole (160/800 mg twice daily) and metronidazole (500 mg twice daily), owing to excellent polymicrobial coverage.

[117] We performed a thorough search for published and unpublished trials conducted or published before 2008 on any probiotic used ... in metronidazole-treated women. Metronidazole 500 mg orally ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

The aim of this study was to evaluate the effectiveness of a single daily high dose probiotic preparation (VSL#3) in maintaining antibiotic induced remission ... 18 = worst), in whom remission was ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Becton Dickinson & Co. $232.97-12.09-4.93% ...

Table 2. Dominant microglial factors in GF and ABX-treated mice at 6–10 weeks of age. Moreover, the consequence of defective microglia on viral genes expression and virus loading in the CNS of GF mice ...